TOKYO, April 22, 2025 – FUJIFILM Holdings Corporation is pleased to announce that 23 of its products including imaging and medical devices have been awarded the “Red Dot Design Award: Product Design 2025,” a product design award program organized by the Design Zentrum Nordrhein Westfalen based in Essen, Germany.
The Red Dot Design Award is an international design award program launched in 1955. The award is given to outstanding products that have been judged on criteria such as design innovation, functionality, ergonomics, ecology and durability. The Red Dot Design Award is considered one of the top three global design awards, along with the iF Design Award in Germany and the International Design Excellence Award (IDEA) in the United States. As a result of the judging by internationally renowned design experts, 23 of the company's products have received the “Red Dot Design Award: Product Design 2025”.
In developing all of its products and services, Fujifilm not only pursues functionality and performance, but also engages in design development that leverages superior functionality and performance. Fujifilm will continue to work on creating designs that not only have beautiful appearance but also reflect commitment to offering portability and operability for ease of use and comfort, thereby creating new product values.

“Red Dot Design Award 2025” logo




“FUJIFILM X100VI” Limited Edition















- * Available products vary by region.

- * Available products vary by region.

- * instax is registered trademarks or trademarks of FUJIFILM Corporation.
Contact
FUJIFILM Holdings Corporation
Design Strategy Office
E-mail : dgi-101-FH-DSO@fujifilm.com
- * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.
- * This news release is issued by FUJIFILM Holdings Corporation in Japan. Fujifilm makes no representation that products on this news release are commercially available in all countries and regions including the US and EU. Approved uses of healthcare products vary by country and region.